Q2 2019 Holdings
Filed 2019-08-14 | 64 holdings | $24.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $10.0M | 42,700 | 40.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.5M | 64,284 | 22.6% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $3.0M | 25,800 | 12.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $2.5M | 33,800 | 10.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.8M | 36,500 | 7.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.4M | 53,000 | 5.8% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $21.4K | 316,284 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $15.6K | 85,022 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.2K | 156,800 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $13.2K | 142,522 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $12.9K | 98,641 | 0.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.2K | 66,000 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $11.6K | 259,000 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $11.4K | 744,245 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $9.5K | 443,534 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $9.2K | 25,100 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $9.1K | 356,600 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $8.2K | 475,633 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.3K | 23,330 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.7K | 79,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.2K | 33,996 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $5.3K | 82,781 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $4.5K | 146,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $4.2K | 60,900 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.2K | 187,599 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.0K | 26,100 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $3.1K | 128,000 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $3.0K | 11,700 | 0.0% |
| Amarin Corp Plc | Sponsored ADR | 023111206 | $2.7K | 137,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $2.6K | 239,103 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.5K | 104,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $2.2K | 50,949 | 0.0% |
| Intersect Ent Inc | COM | 46071F103 | $2.2K | 96,000 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $2.2K | 17,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.1K | 27,500 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.1K | 60,000 | 0.0% |
| Repligen Corp(RGEN) | COM | 759916109 | $2.1K | 24,000 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $2.1K | 177,825 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $1.9K | 11,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.6K | 145,154 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $1.6K | 150,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.6K | 17,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.6K | 70,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $1.5K | 30,000 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $1.5K | 28,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.3K | 10,700 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $1.2K | 30,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.1K | 10,900 | 0.0% |
| Myriad Genetics inc(MYGN) | COM | 62855J104 | $1.1K | 40,000 | 0.0% |
| Globus Med Inc(GMED) | COM | 379577208 | $1.0K | 24,200 | 0.0% |